|
⚲
|
| Keyboard |
| Alspaugh Jonathan
✚
|
|
|---|---|
| CIK # | 0001868112 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001868112] | |
| 4 | [0001868112] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Alspaugh Jonathan | |
| Spyre Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 19,787,969 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2023-02-23 | Grant | 640,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2022-08-23 | Grant | 130,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2022-03-11 | Buy | 75,000 | $2.08 | 156,000 |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2022-02-17 | Grant | 170,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-12-09 | Buy | 50,000 | $3.72 | 186,000 |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-08-18 | Buy | 7,200 | $6.72 | 48,384 |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-08-17 | Buy | 23,392 | $6.50 | 152,048 |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2021-08-16 | Buy | 9,780 | $6.37 | 62,299 |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2021-07-06 | Grant | 160,000 | $0.00 |